Skip to main content

Table 2 Dosimetry characteristics for patients undergoing monotherapy (I-125) in PPB Group (n = 273)

From: Comparison of biochemical failure rates between permanent prostate brachytherapy and radical retropubic prostatectomy as a function of posttherapy PSA nadir plus ‘X’

Characteristic

Median (IQR)

Prostate volume, mL

39.7 (31–47)

mCi implanted

42.6 (36.4-48.2)

Prostate D90, Gy

158 (146–174)

Prostate V100,%

94.7 (90.3-97.8)

Rectal V100, mL

0.28 (0.01-1.08)

  1. Abbreviations: D90, isodose enclosing 90% of the prostate; IQR, interquartile range; PPB, permanent prostate brachytherapy; V100, target volume receiving 100% of the prescribed dose.